US EditionPublished • loading... • Updated
Controversial US-Backed Vaccination Study Begins In Guinea-Bissau
Summary by Health Policy Watch
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Controversial US-Backed Vaccination Study Begins In Guinea-Bissau
A US government-funded trial on the timing of hepatitis B vaccinations, which will delay vaccination for up to 7,000 newborns in Guinea-Bissau, started this week. The US Centers for Disease Control and Prevention (CDC) has awarded a controversial Danish research group a $1,6 million five-year grant to study the “optimal timing and delivery of monovalent […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
